TLR4 and lung carcinoma: Foxp3 expression, controlled by activated Toll-like receptor 4 (TLR4), enhances immunosuppressive functions of Tregs by inducing inhibitory cytokine secretion and facilitate lung cancer cells to escape the immune system.